Suppr超能文献

缓激肽未参与血管紧张素转换酶抑制剂对自发性高血压大鼠的血管交感神经抑制作用。

Lack of involvement of bradykinin in the vascular sympathoinhibitory effects of angiotensin converting enzyme inhibitors in spontaneously hypertensive rats.

作者信息

Chauvin B, Richer C, Giudicelli J F

机构信息

Département de Pharmacologie, Faculté de Médecine Paris-Sud, Le Kremlin-Bicêtre, France.

出版信息

Br J Pharmacol. 1995 Oct;116(4):2229-36. doi: 10.1111/j.1476-5381.1995.tb15058.x.

Abstract
  1. The aim of this study was to investigate the contribution of endogenous bradykinin to the vascular sympathoinhibitory effects exerted by angiotensin I converting enzyme inhibitors (ACEIs) in the spontaneously hypertensive rat (SHR). 2. Adult SHRs were treated daily for 8 days with either perindopril (3 mg kg-1), or a selective angiotensin II AT1 receptor antagonist, losartan (10 mg kg-1) both given orally--these two doses being equipotent in inhibiting angiotensin I (AI)-induced vascular responses--or distilled water (controls). After pithing, the animals were instrumented for determination of blood pressure, heart rate, cardiac output, regional (renal, mesenteric, hindlimb) blood flows (pulsed Doppler technique) and corresponding vascular resistances. Afterwards, half of the animals of each group were given the selective bradykinin B2 receptor antagonist, icatibant, used in a dose (10 micrograms kg-1, i.v.) that achieved B2 receptor blockade, the other half received saline (10 microliters kg-1, i.v.). Haemodynamic responses to increasing frequencies of spinal cord stimulation were then measured. 3. Pressor and vasoconstrictor responses to AI were significantly and similarly reduced in both perindopril- and losartan-treated groups. Perindopril and losartan both decreased to a similar extent the pressor and vasoconstrictor responses to electrical stimulation of the spinal cord. 4. In the dose used, icatibant did not affect any of the investigated haemodynamic parameters in any of the experimental groups. Furthermore, icatibant did not affect the stimulation frequency-response curves in the control animals and did not modify the vascular sympathoinhibitory effects exerted by perindopril and by losartan. 5 Taken together, these results demonstrate that endogenous bradykinin does not, through B2 receptor activation, contribute to the vascular sympathoinhibitory effects of ACEIs in SHRs.
摘要
  1. 本研究的目的是探讨内源性缓激肽在自发性高血压大鼠(SHR)中对血管紧张素I转换酶抑制剂(ACEIs)所发挥的血管交感抑制作用的贡献。2. 成年SHR每日口服培哚普利(3 mg·kg-1)或选择性血管紧张素II AT1受体拮抗剂氯沙坦(10 mg·kg-1),持续8天,这两种剂量在抑制血管紧张素I(AI)诱导的血管反应方面等效,对照组给予蒸馏水。处死后,将动物进行仪器安装以测定血压、心率、心输出量、局部(肾、肠系膜、后肢)血流量(脉冲多普勒技术)及相应的血管阻力。之后,每组动物的一半给予选择性缓激肽B2受体拮抗剂艾替班特,剂量为(10 μg·kg-1,静脉注射),以实现B2受体阻断,另一半给予生理盐水(10 μl·kg-1,静脉注射)。然后测量对脊髓刺激频率增加的血流动力学反应。3. 培哚普利组和氯沙坦组对AI的升压和血管收缩反应均显著且相似地降低。培哚普利和氯沙坦对脊髓电刺激的升压和血管收缩反应降低程度相似。4. 在所用剂量下,艾替班特对任何实验组中所研究的血流动力学参数均无影响。此外,艾替班特不影响对照动物的刺激频率-反应曲线,也不改变培哚普利和氯沙坦所发挥的血管交感抑制作用。5. 综上所述,这些结果表明内源性缓激肽不会通过B2受体激活对SHR中ACEIs的血管交感抑制作用产生影响。

相似文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验